Merck KGaA
XETRA:MRK
Merck KGaA
XETRA:MRK
Price:
148.95 EUR
-0.67%
Updated:
May 1, 2024
Merck KGaA
Operating Income
|
Merck KGaA
Operating Income Peer Comparison
Comparables:
ATAI
BAYN
93M1
DMP
PSG
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Merck KGaA
XETRA:MRK
|
Operating Income
€4.2B
|
CAGR 3-Years
11%
|
CAGR 5-Years
15%
|
CAGR 10-Years
7%
|
|
|
ATAI Life Sciences NV
NASDAQ:ATAI
|
Operating Income
-$125.5m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bayer AG
XETRA:BAYN
|
Operating Income
€8.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
5%
|
|
|
MPH Health Care AG
XETRA:93M1
|
Operating Income
-€975.1k
|
CAGR 3-Years
-3%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
Dermapharm Holding SE
XETRA:DMP
|
Operating Income
€201m
|
CAGR 3-Years
12%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
|
PharmaSGP Holding SE
XETRA:PSG
|
Operating Income
€17.8m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
See Also
What is Merck KGaA's Operating Income?
Operating Income
4.2B
EUR
4.2B
EUR
Based on the financial report for Dec 31, 2023, Merck KGaA's Operating Income amounts to 4.2B EUR.
What is Merck KGaA's Operating Income growth rate?
Operating Income CAGR 10Y
7%
7%
Over the last year, the Operating Income growth was -20%. The average annual Operating Income growth rates for Merck KGaA have been 11% over the past three years , 15% over the past five years , and 7% over the past ten years .
You don't have any saved screeners yet
